transitional cell carcinoma of the corpus uteri
ORPHA: 2137461 Treatment Available
Overview
transitional cell carcinoma that involves the body of uterus
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Pembrolizumab Cold Chain | Injection | FDA Approved | 3 | — |
Classification & Codes
Orphanet Code
ORPHA:213746transitional cell carcinoma of the corpus uteri
| Orphanet | ORPHA:213746 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO